A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe…

Overview of attention for article published in Trials, July 2020

Altmetric Badge

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 290 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY VIRUSES

Application WO-2021211940-A1

World Intellectual Property Organisation (WIPO)